(Q88532163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Trypanosoma cruzi

1 reference

3

Jean-Robert Ioset

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Gyongseon Yang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nakyung Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Joo Hwan No

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

13 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

125-134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

The metabolism and cytotoxic effects of formycin B in Trypanosoma cruzi

25 March 2020

cites work

1 reference

12 December 2020

The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro

1 reference

12 December 2020

Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine

1 reference

12 December 2020

1 reference

12 December 2020

Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

1 reference

12 December 2020

Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines

1 reference

12 December 2020

Inhibitory action of the antitumor agent lonidamine on mitochondrial respiration of Trypanosoma cruzi and T. brucei

1 reference

12 December 2020

Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections.

1 reference

12 December 2020

In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds

1 reference

12 December 2020

Inhibitory effect of the blood on the lethal anticrithidia Trypanosoma cruzi activity of menadione in vitro

1 reference

12 December 2020

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

1 reference

12 December 2020

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development

1 reference

12 December 2020

Chagas disease in Spain, the United States and other non-endemic countries

1 reference

12 December 2020

Stage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screening

1 reference

12 December 2020

Pentamidine exerts in vitro and in vivo anti Trypanosoma cruzi activity and inhibits the polyamine transport in Trypanosoma cruzi

1 reference

12 December 2020

Polyamines in Trypanosoma cruzi

1 reference

12 December 2020

In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease

1 reference

12 December 2020

Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease

1 reference

12 December 2020

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

1 reference

12 December 2020

Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.

1 reference

12 December 2020

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

1 reference

12 December 2020

Methodological advances in drug discovery for Chagas disease

1 reference

12 December 2020

Cellular transport and lipid interactions of miltefosine

1 reference

12 December 2020

An image-based algorithm for precise and accurate high throughput assessment of drug activity against the human parasite Trypanosoma cruzi

1 reference

12 December 2020

Structural, ultrastructural studies and evolution of Trypanosoma cruzi-infected mice treated with thioridazine

1 reference

12 December 2020

Antitrypanosomal Effect of Allopurinol: Conversion in Vivo to Aminopyrazolopyrimidine Nucleotides by Trypanosoma cruzi

1 reference

12 December 2020

Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease

1 reference

12 December 2020

Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.

1 reference

12 December 2020

Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole

1 reference

12 December 2020

Identifiers

DOI

10.1177/1087057116673796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27729503%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference